Security key
M47238106
- Security type / class
- Equity / SHS
- Total 13F shares
- 6,264,175
- Total 13F value
- $19,483,000
- Share change
- -383,940
- SEC-reported price per share
- $3.11
- Number of holders
- 21
- Value change
- -$1,308,952
- Number of buys
- 9
- Number of sells
- 11
Report period
Q4 2020
Institutions
21
Top holders
10
GLMD full security history
Ownership snapshot
Full 13F holder table
Galmed Pharmaceuticals Ltd. SEC filings
Galmed Pharmaceuticals Ltd. company facts
Broader feeds
Ownership snapshot
Top reported holders of GLMD - GALMED PHARMACEUTICALS LTD - SHS (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Nantahala Capital Managem...
Disclosed value leader
Nantahala Capital Managem...
Comparable rows
0/15
Latest evidence
30 Sep 2020
13F
Highest disclosed value: $7,317,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Nantahala Capital Management, LLC has the largest disclosed position value at $7.32M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Nantahala Capital Management, LLC's linked filing trail.
Disclosed position value
Top 5
Nantahala Capital Management, LLC
$7.32M
BVF INC/IL
$6.35M
IBEX INVESTORS LLC
$5.35M
RAYMOND JAMES & ASSOCIATES
$807K
BAKER BROS. ADVISORS LP
$725K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC |
13F
Company
|
—
denominator unverified
|
$7,317,000
2,072,745 shares
|
— | 30 Sep 2020 |
| BVF INC/IL |
13F
Company
|
—
denominator unverified
|
$6,353,000
1,799,694 shares
|
— | 30 Sep 2020 |
| IBEX INVESTORS LLC |
13F
Company
|
—
denominator unverified
|
$5,348,000
1,515,000 shares
|
— | 30 Sep 2020 |
| RAYMOND JAMES & ASSOCIATES |
13F
Company
|
—
denominator unverified
|
$807,000
228,569 shares
|
— | 30 Sep 2020 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
—
denominator unverified
|
$725,000
205,375 shares
|
— | 30 Sep 2020 |
| P.A.W. CAPITAL CORP |
13F
Company
|
—
denominator unverified
|
$706,000
200,000 shares
|
— | 30 Sep 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
21
Shares
6,264,175
Rows available
21
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
23
Q4 2020 holders
21
Holder diff
-2
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 value | Q4 2020 value | Value change | Value Chg % |
|---|